| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/17/2007 | US20070111967 Organosilicon compounds and their use |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070111934 Procaspase 1 activation inhibitor |
| 05/17/2007 | US20070111927 Peptoid compounds |
| 05/17/2007 | US20070111266 Antibodies to murine zcytor17 ligand |
| 05/17/2007 | US20070110766 Proteinase K resistant surface protein of neisseria meningitidis |
| 05/17/2007 | US20070110763 Polypeptides of streptococcus pyogenes |
| 05/17/2007 | US20070110758 Method for inhibiting bacterial colonisation |
| 05/17/2007 | US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/17/2007 | US20070110714 Medicinal composition for treatment of chronic hepatitis c |
| 05/17/2007 | US20070110708 Silicon compounds and their use |
| 05/17/2007 | US20070108405 Compositions and methods for delivery of biologically active agents |
| 05/16/2007 | EP1785486A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/16/2007 | EP1785426A1 Novel carbapenem compound |
| 05/16/2007 | EP1785143A2 Vaccine composition against hepatitis c virus |
| 05/16/2007 | EP1784492A2 Multiple rna polymerase iii promoter expression constructs |
| 05/16/2007 | EP1784416A2 Vaccines against aids comprising cmv/r - nucleic acid constructs |
| 05/16/2007 | EP1784410A2 Antibacterial agents |
| 05/16/2007 | EP1784407A1 2-arylmethylazetidine carbapenem derivatives and preparation thereof |
| 05/16/2007 | EP1784222A1 Nutritional composition comprising indigestible oligosaccharides |
| 05/16/2007 | EP1784221A2 Methods for the treatment and prevention of infection using anti-selectin agents |
| 05/16/2007 | EP1784220A2 Bacterial iron acquisition targets |
| 05/16/2007 | EP1784218A1 Nutricional composition comprising immunoglobulins and oligosaccharides |
| 05/16/2007 | EP1784217A1 Treatment of hiv infection by t-cell modulation |
| 05/16/2007 | EP1784206A2 Antimicrobial peptides derived from cap18 |
| 05/16/2007 | EP1784200A1 Method and composition for modulation of systemic inflammatory responses syndrome (sirs) |
| 05/16/2007 | EP1784198A2 Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases |
| 05/16/2007 | EP1784189A1 Modulators of hcv replication |
| 05/16/2007 | EP1784180A2 2-amino 1h imidazo ring systems and methods |
| 05/16/2007 | EP1784178A1 Aryl (or heteroaryl) azolylcarbinols |
| 05/16/2007 | EP1784176A1 Composition comprising lactic acid and lactoferrin |
| 05/16/2007 | EP1490407B1 Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40 |
| 05/16/2007 | EP1453846B1 14 or 15 membered macrolides with antibacterial activity |
| 05/16/2007 | EP1372700B1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 05/16/2007 | EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 05/16/2007 | EP1262181B1 Use of isothiazole derivatives as urease inhibitors for the treatment of helicobacter pylori induced gastrointestinal diseases |
| 05/16/2007 | EP1169340B1 Lantibiotic |
| 05/16/2007 | EP0930894B1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 05/16/2007 | CN1964979A Novel water-soluble prodrug |
| 05/16/2007 | CN1964956A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 05/16/2007 | CN1964944A Indole derivatives as antiviral agents |
| 05/16/2007 | CN1964630A Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 05/16/2007 | CN1962693A Long-acting thymosin alpha1 polyethylene glycol modifier |
| 05/16/2007 | CN1962690A Oxya chinensis(Thunberg) imago antibacterial protein preparation method |
| 05/16/2007 | CN1962615A Diamine compound for resisting hepatitis B virus and its preparation method and its application |
| 05/16/2007 | CN1962596A Ketone compounds and compositions for cholesterol management and related uses |
| 05/16/2007 | CN1961943A Pharmaceutical composition for treating cold, its preparation method and quality control method thereof |
| 05/16/2007 | CN1961888A Lyophilized powder injection of baikal skullcap root extract and preparation method thereof |
| 05/16/2007 | CN1961885A Tetracycline derivatives and methods of use thereof |
| 05/16/2007 | CN1961878A Streptogramin derivatives, their preparation and compositions containing them |
| 05/16/2007 | CN1961875A A liver-benefiting kidney-nourishing detoxifying dampness-removing medicament for treating hepatitis |
| 05/16/2007 | CN1961871A An elemene formulation and preparation method thereof |
| 05/16/2007 | CN1961679A A compound antivirus sprayer and preparation method thereof |
| 05/16/2007 | CN1315863C Beta-L-2'-deoxygenation-ramification of nucleotide, synthetic method and application of medication |
| 05/16/2007 | CN1315862C Methods and compositions for treating flaviviruses and pestiviruses |
| 05/16/2007 | CN1315859C Lincomycin derivatives possessing antibacterial activity |
| 05/16/2007 | CN1315846C Crystalline hydrochloride of 7-(((5-amino-1, 2, 4-thiadiazol-3-yl)(fluoromethoxyimino) acetyl) amino) -3- ((imino-1-piperazinylmethyl)methylhydrazono)-methyl-3-cephem-4-carboxylic acid |
| 05/16/2007 | CN1315845C Methylene containing aminobeterocycle substitutional cephalosporin of amidinothioacetamide, preparation method and application |
| 05/16/2007 | CN1315844C Derivant of gamma carbon alkenyl cephalosporin, preparing method and application |
| 05/16/2007 | CN1315843C Derivant of Deacetoxy cephalosporanicacid, preparation and application |
| 05/16/2007 | CN1315842C Derivant of cephalosporin of amidinothioacetamide, preparation method and application |
| 05/16/2007 | CN1315836C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315830C Substituted purine new compound with anti-HIV activity, preparing method and use |
| 05/16/2007 | CN1315828C Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 05/16/2007 | CN1315824C R- - -1- [2- 7-chlorobenzo [b] thiophen-3 -yl- methoxy -2- 2,4-dichlorophenyl -ethyl] -1h-imidazole |
| 05/16/2007 | CN1315535C Adjuvant for improving hepatitis B vaccine immune effect and preparing method thereof |
| 05/16/2007 | CN1315533C Inactivate pig parvovirus disease oil emulsion vaccine |
| 05/16/2007 | CN1315532C Compound lysoamidase spray agent and preparing method |
| 05/16/2007 | CN1315528C Ginger carminative oral lozenge |
| 05/16/2007 | CN1315527C Externally used cold-evil expelling prepn |
| 05/16/2007 | CN1315522C Medicine for treating tuberculosis, and its prodn. method |
| 05/16/2007 | CN1315518C Hepatic disease treating medicine |
| 05/16/2007 | CN1315514C Heat-clearing and detoxicating effervescence tablet and its preparing process |
| 05/16/2007 | CN1315511C Effervescence tablet of antiviral medicine and its preparation process |
| 05/16/2007 | CN1315510C Antiviral composition derived from allium cepa and therapeutic use thereof |
| 05/16/2007 | CN1315503C Compound Chinese medicine preparation for curing asthma and assisted curing tumor and AIDS and its preparing method |
| 05/16/2007 | CN1315489C New use of fleahane preparation for teating acute respiratory distress syndrome |
| 05/16/2007 | CN1315482C Inhibition of systemic infections in humans and vertebrates by dietary fibers |
| 05/16/2007 | CN1315480C Herpes virus treating medicine composition and its production process |
| 05/16/2007 | CN1315477C Composition of cefuroxime sodium and tazobactam sodium for injection |
| 05/16/2007 | CN1315470C Compound liver-benefiting dropping pill for treating hepatitis and its preparing method |
| 05/16/2007 | CN1315468C Liver-benefiting dropping pill prepared from total neterosides of swertia mileensis, and its preparing method |
| 05/16/2007 | CN1315467C liver-clearing dropping pill for treating hepatitis and its preparing method |
| 05/16/2007 | CN1315461C Jaundice capillaris drip pill and its preparation method |
| 05/15/2007 | USRE39634 treatment of neuropathic pain; elevate levels of anandamide or other endogenous cannabinoids to increase the nociceptive threshold |
| 05/15/2007 | US7217805 Bicyclonucleoside analogues |
| 05/15/2007 | US7217730 Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus |
| 05/15/2007 | US7217729 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies |
| 05/15/2007 | US7217726 Oxazolidinon-3-ylphenyl -piperazine, -imidazolidine, and -diazepine derivatives, e.g., S)-N-[3-[3-Fluoro-4-[4-(5-nitrofuran-2-ylthiocarbonyl)piperazin-1-yl]phenyl]-2-oxooxazolidin-5-ylmethyl]thioacetamide; treating bacterial infections, particularly those that are antibiotic resistant |
| 05/15/2007 | US7217721 8-Azabicyclo[3.2.1]octane derivatives of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridines, used for modulating chemokine CCR5 receptors for treating retroviral infections and inflammatory diseases |
| 05/15/2007 | US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses |
| 05/15/2007 | US7217713 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 05/15/2007 | US7217694 Inhibitors of IAPP fibril formation and uses thereof |
| 05/15/2007 | US7217534 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 05/15/2007 | US7217420 Protective formulation that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes; formulation comprises a protective amount of live MG strain K5054 or derivatives |
| 05/15/2007 | US7217419 Vaccine for preventing cervical cancer |
| 05/15/2007 | US7217418 Administering an attenuated dengue-1 (DEN-1) virus composition |
| 05/15/2007 | US7217415 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase for therapeutic use |